Regulatory
FDA Approves Mimrylo, a First-of-Its-Kind Drug for the Blood Disorder Polycythemia Vera
Rusfertide mimics the body’s iron-regulating hormone to rein in red-blood-cell overproduction — and in a trial, most patients no longer needed regular blood draws.